ABOUT THIS EPISODE
Dr Stephanie Gaglione discusses scalable technologies to map T cell receptor antigen interactions, enabling large datasets that could transform how we study immune recognition and build computational models of immunity. In this episode of 'Immunity by Design', Dr Hashem Koohy speaks with Dr Stephanie Gaglione about new experimental approaches that could transform how we study T cell recognition. At the heart of adaptive immunity lies the interaction between T cell receptors (TCRs) and antigenic peptides presented by MHC molecules. However, mapping these interactions at scale has remained one of the central challenges in immunology.
Dr Gaglione discusses her work on scalable strategies for reconstructing and screening large numbers of TCRs, including the TCRAFT approach developed during her PhD with Michael Birnbaum at MIT. By enabling the reconstruction of thousands of TCRs from sequence data and integrating functional screening technologies such as RAPTR, these methods open the door to generating high-quality datasets linking TCR sequences to antigen specificity.
The conversation explores the technological hurdles of many-to-many TCR antigen screening, the importance of accessible experimental tools for building community-scale datasets, and how such data could accelerate the development of computational models that predict immune recognition. The episode also touches on applications in autoimmune disease, including vitiligo, and the broader implications for immunology, cancer research, and data driven discovery.
Dr Gaglione discusses her work on scalable strategies for reconstructing and screening large numbers of TCRs, including the TCRAFT approach developed during her PhD with Michael Birnbaum at MIT. By enabling the reconstruction of thousands of TCRs from sequence data and integrating functional screening technologies such as RAPTR, these methods open the door to generating high-quality datasets linking TCR sequences to antigen specificity.
The conversation explores the technological hurdles of many-to-many TCR antigen screening, the importance of accessible experimental tools for building community-scale datasets, and how such data could accelerate the development of computational models that predict immune recognition. The episode also touches on applications in autoimmune disease, including vitiligo, and the broader implications for immunology, cancer research, and data driven discovery.
English
United Kingdom
IN THIS EPISODE
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SEARCH PAST EPISODES
Search past episodes of Immunity By Design.
OTHER EPISODES IN THIS PODCAST
Prof Hashem Koohy is joined by Dr Timothy Jenkins to explore how AlphaFold and experimental technologies are transforming antibody discovery, enabling molecules that neutralise multiple snake venom toxins. Snakebite envenoming remains one of the most neglected global health challenges, causing over…
Professor David Gfeller discusses interpretable AI, TCR specificity profiles, cross-reactivity, chain pairing, and why understanding T cell recognition may matter more than black-box prediction. In this episode of Immunity by Design, Prof Hashem Koohy speaks with Professor David Gfeller (University…
Dr Agne Antanaviciute joins Prof Hashem Koohy to discuss how spatial omics and single-cell technologies
uncovered the hidden biology of Crohn’s fistula and revealed fibroblasts as key drivers of disease. Crohn’s fistula is one of the most severe and understudied complications of inflammatory bowel …
In this episode of Immunity by Design, Prof Hashem Koohy is joined by Dr Timothy Jenkins. The conversation explores how AlphaFold and experimental technologies are transforming antibody discovery, enabling the design of molecules that can neutralise multiple snake venom toxins simultaneou…
Disclaimer: The podcast and artwork embedded on this page are from Oxford University, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.